Abstract
The thermal [3+2] cycloaddition reaction of N-acyliminophenanthridinium betaines with various allenoates has been investigated. The reaction was operationally simple and proceeded smoothly under mild reaction conditions, providing a variety of aromatic tetracyclic heterocycles in moderate to excellent yields.
Keywords: Cycloaddition, azomethine imine, allenoate, heterocycle, phenanthridine.
Letters in Organic Chemistry
Title:Thermal [3+2] Cycloaddition Reaction of N-Acyliminophenanthridinium Betaine with Allenoates: Facile Access to Phenanthridine-fused Tetracyclic Heterocycles
Volume: 11 Issue: 3
Author(s): Zhen Li, Hao Yu, Lei Zhang, Honglei Liu, Risong Na, Qinghua Bian, Min Wang and Hongchao Guo
Affiliation:
Keywords: Cycloaddition, azomethine imine, allenoate, heterocycle, phenanthridine.
Abstract: The thermal [3+2] cycloaddition reaction of N-acyliminophenanthridinium betaines with various allenoates has been investigated. The reaction was operationally simple and proceeded smoothly under mild reaction conditions, providing a variety of aromatic tetracyclic heterocycles in moderate to excellent yields.
Export Options
About this article
Cite this article as:
Li Zhen, Yu Hao, Zhang Lei, Liu Honglei, Na Risong, Bian Qinghua, Wang Min and Guo Hongchao, Thermal [3+2] Cycloaddition Reaction of N-Acyliminophenanthridinium Betaine with Allenoates: Facile Access to Phenanthridine-fused Tetracyclic Heterocycles, Letters in Organic Chemistry 2014; 11 (3) . https://dx.doi.org/10.2174/1570178610666131120003018
DOI https://dx.doi.org/10.2174/1570178610666131120003018 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Monoclonal Antibodies - Regulatory Challenges
Current Pharmaceutical Biotechnology Recent Advances in the Medicinal Chemistry of Aurones
Current Medicinal Chemistry Subject Index To Volume 3
Current Drug Delivery Editorial: [Exciting Discoveries About New p53 Target Genes, Cancer Drugs and Diagnostic Tools, and Mechanisms of Various Human Diseases]
Current Molecular Medicine Current Methods of the Circulating Tumor Cells (CTC) Analysis: A Brief Overview
Current Pharmaceutical Design Meet Our Editorial Board Member
Combinatorial Chemistry & High Throughput Screening Formulation and Evaluation of Polymeric Nanomicelles of Gliptin for Controlled Drug Delivery
Drug Delivery Letters Molecular Mistletoe Therapy: Friend or Foe in Established Anti-Tumor Protocols? A Multicenter, Controlled, Retrospective Pharmaco-Epidemiological Study in Pancreas Cancer
Current Molecular Medicine Monoclonal Antibodies: A Target Therapy for Multiple Sclerosis
Inflammation & Allergy - Drug Targets (Discontinued) Investigation Binding Patterns of Human Carboxylesterase I (hCES I) with Broad Substrates by MD Simulations
Current Topics in Medicinal Chemistry Chemical Modifications of Ketoprofen (NSAID) in Search of Better Lead Compounds: A Review of Literature From 2004-2016
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Recent Approaches for Studying the Role of Glia
CNS & Neurological Disorders - Drug Targets Nanotechnology as a Promising Strategy for Anticancer Drug Delivery
Current Drug Delivery Current Concepts in the Diagnosis and Treatment of Type 1 and Type 2 Autoimmune Pancreatitis
Recent Patents on Inflammation & Allergy Drug Discovery Understanding Tumor-Antigen Presentation in the New Era of Cancer Immunotherapy
Current Pharmaceutical Design Counter-Regulatory Role of Bile Acid Activated Receptors in Immunity and Inflammation
Current Molecular Medicine Gene Polymorphisms and Pharmacogenetics in Rheumatoid Arthritis
Current Genomics MicroRNA-208a Potentiates Angiotensin II-triggered Cardiac Myoblasts Apoptosis via Inhibiting Nemo-like Kinase (NLK)
Current Pharmaceutical Design Formulations, Pharmacodynamic and Clinical Studies of Nanoparticles for Lung Cancer Therapy - An Overview
Current Drug Metabolism Recent Advances of Small Molecule Focal Adhesion Kinase (FAK) Inhibitors as Promising Anticancer Therapeutics
Current Medicinal Chemistry